Zenas BioPharma Announces Key 2024 Accomplishments and 2025 Business Objectives to Support the Global Development and Commercialization of Therapies for Autoimmune Diseases
Notified -
Globe Newswire5-02-2025, 19:05
Mavenir and EdgeQ Introduce Industry’s First Software-Defined 4G and 5G Next Generation Small Cells for Neutral Host and Urban Densification 18-02-2025, 21:00